Novotech, the leading Asia Pacific biotech specialist CRO, has again received “Best Workplace” certification by the leading workplace culture organization Great Place to Work Institute. Novotech’s India team has received a Best Workplaces for Women 2022 recognition and listed in the Top 75 organisations in India recognised for excelling people practices, responsiveness to feedback and a culture of openness and diversity.   

Novotech also holds Great Place to Workplace recognition in Australia and Korea.

To identify India’s Best Workplaces for Women 2022, Great Place to Work India studied 1122 organizations that had: 

  • Women employees constituting at least 10% of their workforce
  • Women employees sharing at least 70% positive feedback on the Great Place to Work Trust Index Organizations that excelled in gender parity in representation

According to Great Place to Work India:

“We have observed that the Best Workplaces have gone above and beyond to create and sustain aspirational organizations. 

We congratulate Novotech for being a role-model in India by fostering an equal and equitable workplace culture.”

Novotech CEO Dr. John Moller said: 

“As a leading employer of women in India we are extremely pleased to be ranked among the top companies in India as a Best Workplaces for Women 2022. This is especially important for retaining and attracting top talent.” 

This recognition demonstrates the importance of culture, diversity and work life balance as we strive to be one of the leading employers so we can deliver our world-class CRO services across India.” 

Novotech’s Chief People Officer Angela Edwardson said:

“We are delighted that Novotech India has been recognized as a leading employer for women. This is a real credit to our workplace culture and leadership that drives all our Asia Pacific and North American teams.  

Novotech attracts a high proportion of talented female employees, so we are extremely proud to have our workplace recognized using the criteria from the Great Place to Work Institute’s Trust Index and the Gender Parity in Experience & Representation.

Our continued focus on building a leading workplace means team members can balance their personal responsibilities with work during all stages of life.”

According to Yooni Kim, Vice President, Global Clinical Services Novotech:

“Employees are the most valuable assets of a company.  Novotech is dedicated to improving our working environment and enhance employee health and wellbeing. We are more than grateful to receive this recognition.” 

Sridevi Gubbala, Manager Centralized Document Management Novotech said: 

“Novotech is a great place to work. It’s wonderful to have flexibility at work because it helps me balance my work and personal life.” 

Vandana Jaising, Manager Project Support joined Novotech after an extended career break and said: 

“Women should consider coming back, even if it is has been a while. Before joining Novotech I took an eight-year career break, and now I’m glad Novotech had the confidence in me to say ‘YES! You can do it!”

Novotech has operations across Asia Pacific and the US offering a unique and unparalleled suite of CRO services for early to late phase biotech clinical research.

Novotech has recently been benchmarked as a top 10 CRO among the world’s leading CROs, is a finalist in the prestigious Scrip awards, and has just been awarded the Gene & Cell Therapy Excellence Award. 

In Asia Pacific Novotech has more than 50 Leading Site Partnership agreements with major medical research institutions which delivers exclusive benefits for sponsors.

Media contact

노보텍(Novotech) 소개

1997년 설립된 노보텍은 글로벌 full-service CRO이며 바이오텍과 제약회사와의 파트너십을 통해 임상의 모든 단계에서 혁신적이면서도 새로운 치료제 개발을 가속하는 데 주력하고 있습니다.  

노보텍은 CRO 업계에서의 선도적인 역할을 인정받아 다수의 권위 있는 상을 수상하였습니다. 2024년에는 Frost & Sullivan의 Global Biotech CRO Award, Clinical Trials Arena Award for Excellence in Business Expansion, Marketing, and Innovation, Employer of Choice, 미국 Great Place to Work 인증, Brandon Hall Gold Award를 수상하였으며, 2023년에는 CRO Leadership Award와 Asia Pacific Cell & Gene Therapy Clinical Trials Excellence를 수상하였습니다. 또한, 2006년부터 Asia-Pacific Contract Research Organization Company of the Year Award를 수상하며 업계에서의 입지를 공고히 하고 있습니다.

노보텍은 연구소, 임상 1상 시험 기관, 약물 개발 컨설팅 서비스, 규제 전문성 등 종합적인 서비스를 제공하며, 1상에서 4상까지의 임상시험과 생물학적 동등성 연구를 포함해 5000건 이상의 임상 프로젝트에 참여한 경험이 있습니다. 노보텍은 전 세계 지역에 걸쳐 34개 지사와 3000명 이상의 직원을 두고 있으며 신뢰할 수 있는 완전한 형태의 전략 파트너입니다.  

더 자세한 정보나 임상시험 관련 상담을 원하신다면, 노보텍 공식 웹사이트를 (www.Novotech-CRO.com) 방문하시기 바랍니다.